Kluyveromyces marxianus (Saccharomycetaceae) K. marxianus, Milk Yeast

Kluyveromyces marxianus is a remarkable, multi-functional probiotic yeast, distinguished from conventional probiotics by its unique ability to modulate the immune system towards an anti-inflammatory state. Unlike Saccharomyces boulardii, which is known for its robust pro-inflammatory Th1 response, K. marxianus is uniquely positioned as a potent inducer of regulatory T cells (Tregs). This property, combined with its proven safety record and metabolic versatility, makes it an exceptional candidate for managing conditions characterized by excessive inflammation and for pioneering applications in postbiotic development and clinical supportive care.

---

1. Taxonomic Insights

Species: Kluyveromyces marxianus (E.C. Hansen) Van der Walt

Family: Saccharomycetaceae

The Saccharomycetaceae family comprises the true yeasts, characterized by their unicellular, budding growth form and ability to ferment sugars. This family includes some of the most economically and medically important fungi. The genus Kluyveromyces is closely related to Saccharomyces but is distinguished by its unique physiology, including the ability to assimilate lactose and a generally higher thermotolerance.

Taxonomic Note: Kluyveromyces marxianus is a species complex with significant intraspecific polymorphism, meaning different strains can have substantially different properties and applications. The strain designated Kluyveromyces marxianus fragilis B0399 is one of the most extensively studied and commercially developed for human probiotic use.

Related Species from the Same Family:

· Saccharomyces cerevisiae (Baker's/Brewer's Yeast): The most well-known yeast, used for baking, brewing, and as a nutritional supplement.

· Saccharomyces boulardii: A tropical strain of S. cerevisiae, it is the most documented and clinically used probiotic yeast, effective against antibiotic-associated diarrhea and traveler‘s diarrhea.

· Kluyveromyces lactis (Milk Yeast): A close relative of K. marxianus, used in the dairy industry for its β-galactosidase (lactase) production and as a model organism in genetics.

· Candida species: A genus within the same family, including opportunistic pathogens, which highlights the importance of distinguishing between pathogenic and beneficial yeasts.

---

2. Common Names

Scientific Name: Kluyveromyces marxianus | English: Milk Yeast | Italian: Lievito lattico | Trade/Strain Designations: Kluyveromyces marxianus fragilis B0399, Turval B0399, Kluyver B0399 | Spanish: Kluyveromyces marxianus | Japanese: クリベロミセス・マルキシアヌス (Kuriberomisesu marukushianusu) | Product Names: BioVal Plus, BioSympa, LIEVILACTIS (containing B0399)

---

3. Medicinal Uses

Primary Actions: Immunomodulatory (Treg induction), Anti-inflammatory, Probiotic, Postbiotic (bioactive metabolites), Antimicrobial (against pathogens, including Candida), Antioxidant.

Secondary Actions: Lactase activity (lactose digestion), Antidiarrheal, Gastroprotective, Production of short-chain fatty acids, Biofilm inhibition.

Medicinal Parts:

Both live yeast cells (probiotic) and the metabolic products they produce (postbiotics) are used for health benefits.

· Live Yeast (Probiotic): The viable yeast cells, taken as a supplement, colonize the gut transiently and interact directly with the gut-associated lymphoid tissue. The specific strain is crucial.

· Postbiotic (Cell-Free Extract): The bioactive metabolites secreted by K. marxianus, including phenolic acids, enzymes, and peptides. These are heat-stable, safe for immunocompromised individuals, and offer enhanced shelf-life and standardization potential.

---

4. Phytochemicals Specific to the Plant and Their Action

K. marxianus is a yeast, not a plant. Its bioactivity stems from its cellular components and secreted metabolites.

· Cell Wall β-Glucans: The primary immunomodulatory component of the yeast cell wall. They are recognized by the host's immune system via the Dectin-1 receptor on dendritic cells and macrophages. This recognition is the key trigger for the yeast's distinct Immunomodulatory effects, leading to the induction of Foxp3+ Regulatory T cells (Tregs).

· Secreted Enzymes (β-galactosidase, Inulinase, Proteases, β-glucanases): These enzymes confer Lactase activity (breaking down lactose), break down complex plant fibers (inulin), and contribute to Antimicrobial effects by degrading the cell walls of fungal pathogens like Candida albicans.

· Postbiotic Phenolic Compounds: The cell-free supernatant contains a diverse array of bioactive molecules including Fumaric acid, Quercetin, Gallic acid, and Quinic acid. These contribute to the postbiotic‘s Antioxidant and Antimicrobial properties.

· Bioactive Amino Acids (Lysine, Leucine, Glycine): The postbiotic fraction is rich in essential and bioactive amino acids, providing nutritional support and contributing to metabolic functions.

· Fatty Acids (Palmitic acid, Stearic acid, Medium-chain fatty acids): These contribute to the postbiotic‘s Antimicrobial effects, particularly against biofilms of pathogens like Staphylococcus aureus.

---

5. Traditional and Ethnobotanical Uses

K. marxianus has been used in food fermentation for centuries, particularly in traditional dairy products like kefir, as well as in the fermentation of cocoa, coffee, and agave for spirits. This long history of safe use in the food chain is a key pillar of its safety evidence.

Probiotic Immunomodulation & Inflammatory Conditions

Formulation: Live yeast probiotic (e.g., B0399 strain); postbiotic (cell-free extract).

Preparation & Use: K. marxianus B0399 is administered as a dietary supplement, typically in capsule or sachet form, at doses of 1-5 billion CFU per day. It is used to manage conditions linked to excessive inflammation, such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and as a co-adjuvant in cancer therapy to mitigate side effects.

Reasoning: The yeast's β-glucans interact with the Dectin-1 receptor on dendritic cells. This specifically drives the differentiation of naive T cells into Foxp3+ regulatory T cells (Tregs), which are the body's master suppressors of inflammation. This effect is distinct from the Th1-driven pro-inflammatory response induced by S. boulardii.

Supportive Care During Antibiotic and Oncological Therapies

Formulation: Live yeast probiotic.

Preparation & Use: The probiotic is taken to prevent or reduce gastrointestinal side effects like diarrhea during antibiotic treatment or chemotherapy and radiation therapy for cancer.

Reasoning: As a yeast, K. marxianus is inherently resistant to antibacterial antibiotics, allowing it to survive and colonize the gut even when the bacterial microbiota is being suppressed. Its Treg-inducing properties help control the inflammatory damage to the intestinal mucosa often caused by chemo- and radiotherapy. It is also used to prevent fungal overgrowth.

Lactose Intolerance

Formulation: Live yeast probiotic (with high β-galactosidase activity).

Preparation & Use: The yeast is consumed alongside lactose-containing dairy products, or the products themselves can be fermented with the yeast to reduce their lactose content.

Reasoning: K. marxianus possesses a very high level of β-galactosidase (lactase) activity, often higher than the traditional S. cerevisiae or K. lactis. This enzyme breaks down the lactose sugar into absorbable glucose and galactose, alleviating the symptoms of lactose intolerance.

COVID-19 Supportive Care (Clinical Study)

Formulation: A combination probiotic containing K. marxianus B0399 and Lactobacillus rhamnosus CECT 30579.

Preparation & Use: In a randomized clinical trial, the probiotic mixture was administered daily for 30 days to COVID-19 patients as a coadjutant treatment alongside standard care.

Reasoning: The study demonstrated a significant benefit of the probiotic in reducing both digestive (e.g., abdominal pain) and non-digestive symptoms, as well as improving overall symptom resolution. This is attributed to the probiotic's systemic immunomodulatory effect, which helped dampen the hyper-inflammatory response (cytokine storm) characteristic of severe COVID-19.

Postbiotic Applications (Emerging)

Formulation: Cell-free supernatant (postbiotic) from K. marxianus cultures.

Preparation & Use: The inactivated, cell-free postbiotic can be formulated into functional foods, nutraceuticals, or topical preparations.

Reasoning: Postbiotics are stable and safe for populations where live probiotics are contraindicated (e.g., severely immunocompromised individuals). The K. marxianus postbiotic is rich in antioxidant phenolic compounds and has demonstrated strong biofilm-inhibiting activity against pathogens like S. aureus and Cronobacter sakazakii.

---

6. Healing Recipes, Decoctions, and Preparations

K. marxianus is not typically used in home brewing or simple kitchen recipes for medicinal purposes. Its therapeutic application relies on standardized, research-backed preparations.

Standardized Probiotic Supplement

Purpose: For immunomodulation and gastrointestinal health.

Preparation & Use:

1. The specific strain K. marxianus fragilis B0399 is commercially produced in a laboratory setting.

2. It is available in capsules, sachets, or tablets containing a defined number of live colony-forming units (CFU).

3. The typical recommended dosage is 1-2 capsules (1-5 billion CFU) once or twice daily. Follow the manufacturer's or a healthcare professional's instructions.

Kefir (Traditional Fermented Milk)

Purpose: A traditional food source of diverse probiotic microbes, including K. marxianus.

Preparation & Use:

1. Add kefir grains to milk.

2. Ferment at room temperature for 24-48 hours.

3. Strain the grains out and consume the fermented milk, which will contain live K. marxianus and other beneficial bacteria and yeasts.

---

7. In-Depth Pharmacological Profile and Clinical Significance of Kluyveromyces marxianus

Introduction

Kluyveromyces marxianus is rapidly emerging as a next-generation probiotic, distinguished by its unique and powerful immunomodulatory fingerprint. While most probiotics, including the yeast Saccharomyces boulardii, are known for their general health benefits, K. marxianus possesses a specific capacity to regulate the immune system. Its defining feature is its ability to potently induce anti-inflammatory regulatory T cells (Tregs), a characteristic that sets it apart from its better-known cousin, S. boulardii. Beyond this signature action, its metabolic versatility grants it other valuable properties, such as high lactase activity and the production of potent postbiotic metabolites. Backed by a global safety approval, clinical trial data for COVID-19, and a robust body of in vitro research, K. marxianus represents a paradigm shift from simple gut colonization to targeted, immune-mediated therapy.

1. The Signature Action: Immunomodulation and Treg Induction (The Treg Probiotic)

Key Mechanism: β-glucan mediated Dectin-1 receptor activation.

Landmark 2016 Study (PLOS ONE): A pivotal in vitro study directly compared the immune-modulating properties of K. marxianus with S. boulardii using human dendritic cells (DCs) and T cells. The results were striking and distinct. S. boulardii induced a strong pro-inflammatory response, characterized by the secretion of the cytokine IFNγ, which drives a Th1-type immune response (important for fighting intracellular pathogens). In contrast, K. marxianus induced a response dominated by the generation of Foxp3+ regulatory T cells (Tregs). Tregs are the body's primary suppressors of excessive immune responses, responsible for maintaining self-tolerance and preventing chronic inflammation.

Clinical Significance: This discovery positions K. marxianus as a targeted therapy for conditions driven by excessive or inappropriate inflammation, rather than a general immune stimulant. It is an ideal candidate for:

· Inflammatory Bowel Disease (IBD): Crohn's disease and ulcerative colitis are characterized by a dysregulated, hyper-inflammatory immune response in the gut.

· Irritable Bowel Syndrome (IBS): Low-grade inflammation is recognized as a key driver of IBS symptoms.

· Allergies and Atopic Conditions: Treg deficiency is associated with a higher risk of allergic diseases.

· Post-Chemo/Radiation Therapy: These treatments cause significant inflammatory damage to the intestinal mucosa, and Treg induction could help mitigate this damage.

· Post-Infectious Inflammation: Helping to resolve the inflammatory state after an infection, such as the long-term symptoms seen in post-COVID syndrome.

2. Probiotic, Safety, and Clinical Validation

The B0399 Strain: The K. marxianus fragilis B0399 strain is the most commercially developed and studied strain for human health. It has been granted Qualified Presumption of Safety (QPS) status by the European Food Safety Authority (EFSA) and has received regulatory approvals from major health authorities worldwide, including the US FDA, Health Canada, the Brazilian ANVISA, and the Indian FSSAI. It is the first non-Saccharomyces yeast approved for probiotic use in human and animal nutrition.

COVID-19 Clinical Trial (2022): A randomized, open-label clinical trial evaluated the effect of a probiotic mixture containing K. marxianus B0399 and Lactobacillus rhamnosus CECT 30579 in COVID-19 patients. The probiotic group showed statistically significant improvements compared to the control group:

· Fewer digestive symptoms: 100% of patients in the probiotic group were free from pyrosis (heartburn) and abdominal pain by the end of the study, compared to only 33.3% and 62.5% in the control group.

· Greater global symptom improvement: The overall percentage of patients who saw improvement in all symptoms (digestive and non-digestive) was significantly higher in the probiotic group (88.6% vs 70.8%).

· Excellent safety profile: The probiotic was well-tolerated with no relevant side effects and high patient adherence.

Rationale: The benefit is likely due to the Treg-inducing properties of K. marxianus, which helped to dampen the severe, often fatal, hyper-inflammatory response (cytokine storm) triggered by the SARS-CoV-2 virus.

3. Metabolic Versatility: Lactase, Fermentation, and Postbiotics

High β-Galactosidase (Lactase) Activity: K. marxianus is renowned in the dairy industry for its high lactase production. This makes it an effective probiotic for managing lactose intolerance, as it can actively break down lactose in the gut, preventing the bloating, gas, and diarrhea caused by undigested lactose. Its activity is often superior to other dairy yeasts.

Cell Factory for Biotech: Its remarkable thermotolerance (ability to grow at high temperatures) and ability to utilize a wide range of sugars (including lactose and xylose) make it a powerhouse for industrial biotechnology. It is used for bioethanol production from plant waste, the production of enzymes (inulinases, proteases), and the synthesis of valuable aroma compounds.

Postbiotic Potential (2026 Study): A 2026 study identified K. marxianus ETP12 as a top candidate for postbiotic production. The yeast's cell-free extract was characterized, revealing a rich profile of:

· Phenolic Compounds: Including antioxidant quercetin and gallic acid.

· Bioactive Amino Acids: With lysine, leucine, and glycine as predominant components.

· Antimicrobial Activity: The postbiotic demonstrated strong biofilm-inhibiting activity against the dangerous pathogens Staphylococcus aureus and Cronobacter sakazakii.

Significance: Postbiotics offer a safer alternative to live probiotics for use in severely immunocompromised patients, premature infants, and other vulnerable populations. They are also more stable and easier to standardize for industrial applications.

4. Antimicrobial and Antifungal Properties

K. marxianus secretes a variety of hydrolytic enzymes, including β-glucanases, chitinases, and proteases. These enzymes have been shown to directly degrade the cell walls of fungal pathogens, including Candida albicans, a common cause of yeast infections, and Botrytis cinerea, a plant pathogen. This direct antagonistic activity, combined with its ability to compete for nutrients, makes it effective in controlling fungal overgrowth in the gut and on agricultural products.

An Integrated View of Healing with Kluyveromyces marxianus

· For Immune Dysregulation and Chronic Inflammation: K. marxianus is not a general immune stimulant; it is an immune conditioner. Its unique ability to drive the differentiation of Tregs offers a targeted strategy for turning down the dial on excessive inflammation. This makes it a scientifically sound choice for managing the underlying pathophysiology of IBD, severe allergies, and for mitigating the inflammatory damage from cancer treatments. The clinical trial data in COVID-19 provides a powerful proof-of-concept for this action in humans.

· As a Safe and Effective Probiotic for High-Risk Populations: Its approval by multiple global regulatory agencies confirms its exceptional safety profile for the general population. More importantly, the development of its postbiotic offers a path to bring its benefits to those who cannot take live probiotics, such as the severely immunocompromised. This makes the K. marxianus system one of the most versatile and safe in the probiotic field.

· For Targeted Digestive Issues: Its high lactase activity provides a direct, mechanistic solution for lactose intolerance. Its inherent resistance to antibiotics makes it an ideal companion during antibiotic therapy to prevent secondary diarrhea and maintain gut health without being killed by the medication.

Toxicological Profile and Safety

K. marxianus has an excellent safety profile and is generally recognized as safe (GRAS). It has been granted QPS status by the EFSA and approved by regulatory bodies in the USA, Canada, Brazil, India, and China. The specific strain B0399 has been used in human studies with no relevant side effects and high tolerability. As with any live microorganism, caution is theoretically advised for severely immunocompromised individuals, though this risk is mitigated by the availability of the inactivated postbiotic.

Conclusion: Kluyveromyces marxianus is a trailblazing next-generation probiotic, distinguished not by its ability to simply add to the gut flora, but by its sophisticated dialogue with the immune system. Its unique capacity to promote anti-inflammatory regulatory T cells positions it as a targeted therapy for a wide range of inflammatory conditions, a role validated by clinical research in the context of COVID-19. Coupled with its metabolic prowess for digesting lactose and producing valuable postbiotics, K. marxianus transcends the traditional definition of a probiotic. It is a true biological response modifier, a metabolic ally, and a model for the future of functional foods and targeted microbiome therapeutics.

---

Disclaimer:

Kluyveromyces marxianus is generally recognized as safe (GRAS) and has regulatory approval for use as a probiotic. However, individuals who are severely immunocompromised (e.g., undergoing intensive chemotherapy, post-organ transplant) should consult their physician before taking any live probiotic. The specific strain and dosage of K. marxianus can influence its effects; products should be based on well-characterized strains. This information is for educational purposes only and is not a substitute for professional medical advice.

---

8. Reference Books, Books for In-depth Study:

· The Yeasts: A Taxonomic Study by C.P. Kurtzman, J.W. Fell, T. Boekhout

· Handbook of Probiotics and Prebiotics by Yuan Kun Lee and Seppo Salminen

· Fermentation: Effects on Food Properties (relevant chapters on yeast fermentations)

· Microbiology and Technology of Fermented Foods by Robert W. Hutkins

---

9. Further Study: Microbes That Might Interest You Due to Similar Medicinal Properties

1. Saccharomyces boulardii (S. cerevisiae var. boulardii)

· Species: Saccharomyces cerevisiae | Family: Saccharomycetaceae

· Similarities: The other major probiotic yeast. It shares a high safety profile and resistance to antibacterial antibiotics. However, its immunological effect is distinct, driving a potent pro-inflammatory Th1 response. S. boulardii is more appropriate for acute infectious diarrhea, while K. marxianus is better suited for chronic inflammatory conditions.

2. Kluyveromyces lactis

· Species: Kluyveromyces lactis | Family: Saccharomycetaceae

· Similarities: A close relative that shares many metabolic features, including high lactase production. It is also used in the dairy industry but is less studied for the specific Treg-inducing immunomodulatory properties that make K. marxianus unique for managing inflammation.

3. Faecalibacterium prausnitzii

· Species: Faecalibacterium prausnitzii | Family: Ruminococcaceae

· Similarities: One of the most important anti-inflammatory bacterial members of the human gut microbiome. Like K. marxianus, it is known for its potent ability to produce butyrate and other metabolites that induce Treg cells. It represents the bacterial analog of K. marxianus's yeast-based immunomodulation.